CLEVELAND – Could quantum computing be the key to unlocking the mysteries of Alzheimer’s disease and other complex illnesses that have stumped traditional research methods and even supercomputers? IBM and Cleveland Clinic are teaming up to find out.
IBM recently introduced its first quantum computer at a private sector location, selecting Cleveland Clinic as its research partner.
Arvind Krishna, IBM’s Chairman and CEO, stated, “With the launch of IBM Quantum System One at Cleveland Clinic, their exceptional team of researchers can delve into new scientific breakthroughs in biomedical research. By combining quantum computing, artificial intelligence, and other cutting-edge technologies with Cleveland Clinic’s renowned expertise in healthcare and life sciences, we aim to spark a new era of accelerated discovery.”
IBM and Cleveland Clinic are collaborating under a 10-year “Discovery Accelerator” partnership initiated in 2021 to accelerate biomedical research and innovation. The new Quantum System One is specifically designed for healthcare research, marking a significant advancement in the field.
Furthermore, IBM is also implementing high-performance computing via hybrid cloud and artificial intelligence tools.
Dr. Tom Mihaljevic, CEO of Cleveland Clinic, commented, “This technology has the potential to transform healthcare and expedite progress towards new treatments, cures, and solutions for patients. Quantum and other advanced computing technologies will assist researchers in overcoming longstanding scientific challenges and potentially discovering new therapies for diseases such as cancer, Alzheimer’s, and diabetes.”
Key project highlights include:
- Creating quantum computing pipelines to screen and enhance drugs targeting specific proteins;
- Enhancing a quantum-aided prediction model for cardiovascular risk post non-cardiac surgery; and
- Utilizing artificial intelligence to analyze genome sequencing data and vast drug-target databases to identify effective existing medications that could benefit patients with Alzheimer’s and other conditions.
